Skip to content

Effect of Pear Orange and Blood Orange Juices on inflammation and antioxidant activity in individuals with pre-diabetes

Effect of Orange and Blood Orange Juices on the plasma biochemical parametes, functional capacity of monocytes, inflammatory and oxidative stress biomarkers, on individuals diagnosed with insuline resistance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6hhmdz
Enrollment
Unknown
Registered
2020-04-13
Start date
2017-01-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with obesity and insulin resistance, according to the HOMA-IR index.

Interventions

Cross-sectional study, with 23 participants, and oral supplementation of Pera orange juice for 15 days and Moro orange juice, also for 15 days, with 200 ml at lunch and 200 ml at dinner. Between inter
Dietary supplement
G07.203.300.456

Sponsors

Faculdade de Ciências Farmacêuticas
Lead Sponsor
Fundo de Defesa da Citricultura
Collaborator

Eligibility

Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 40 and 60 years, both genders, with nutritional diagnosis of obesity according to the World Health Organization classification (2000) and with diagnosis of insulin resistance according to the HOMA-IR index.

Exclusion criteria

Exclusion criteria: Inflammatory diseases in the gastrointestinal tract, use of supplements or antibiotics and inability to respond to research questionnaires or to perform nutritional status assessments.

Design outcomes

Primary

MeasureTime frame
Reduction of the production of inflammatory cytokines and chemokines after stimulation, measured through quantification tests, in any percentage.;Reduction of phagocytosis and chemotaxis in monocytes, verified through cell culture analyzes, in any percentage.;Increased activity of the antioxidant enzymes catalase, superoxide dismutase and glutathione peroxidase, by testing antioxidant activity, in any percentage.;Reduction of lipid peroxidation markers (8-isoprostanes) and DNA damage (8-OHdG), measured using the ELISA method, in any percentage.

Secondary

MeasureTime frame
Reduction of body weight, through measurement on a scale, in any percentage;Reduction of fasting blood glucose, measured by biochemical examination, to <99 mg / dL;Improvement of the lipid profile, measured by biochemical examination, to the respective values: total cholesterol <190 mg / dL, LDL <100 mg / dL and triglycerides <150 mg / dL);Blood pressure reduction, measured in an automatic pressure device, pulse, to values ??<120 mmHg for systolic blood pressure and <90 mmHg for diastolic blood pressure

Countries

Brazil

Contacts

Public ContactNeuza Hassimotto

Faculdade de Ciências Farmacêuticas

aymoto@usp.br+55-11-3091-3696

Outcome results

None listed

Source: REBEC (via WHO ICTRP)